Table 4 Multiple linear regression analysis of hepatocyte growth factor (HGF) with relevant factors adjusted for confounding factors among women

No. of participants

402

314

Age

1.1

(−0.02, 2.2)

0.055

2.6

(0.8, 4.5)

0.006

Systolic blood pressure

0.4

(−0.6, 1.5)

0.418

−0.7

(−1.7, 0.3)

0.181

Diastolic blood pressure

−0.5

(−1.7, 0.8)

0.450

0.9

(−0.6, 2.3)

0.231

Body mass index (BMI)

3.7

(1.0, 6.3)

0.007

1.5

(−2.7, 5.8)

0.482

Drinking status

−1.8

(−8.0, 4.4)

0.562

4.3

(−6.3, 15.0)

0.426

Smoking status

11.0

(−9.6, 31.6)

0.293

25.2

(−15.2, 65.5)

0.220

Serum HDL cholesterol

−0.8

(−1.5,−0.1)

0.023

−1.0

(−2.0, 0.05)

0.061

Serum LDL cholesterol

−0.2

(−0.6, 0.1)

0.129

−0.4

(−0.8, 0.1)

0.124

Serum triglycerides (TG)

−0.1

(−0.3, 0.04)

0.122

−0.1

(−0.3, 0.2)

0.598

Serum aspartate aminotransferase (AST)

−0.3

(−1.9, 1.2)

0.652

1.4

(−0.5, 3.3)

0.146

Serum γ-glutamyltranspeptidase (γ-GTP)

0.05

(−0.4, 0.5)

0.851

0.5

(−0.5, 1.5)

0.353

Hemoglobin A1c (HbA1c)

11.5

(−10.3, 33.4)

0.301

41.7

(16.6, 66.9)

0.001

Glomerular filtration rate (GFR)

−0.2

(−0.9, 0.5)

0.627

0.3

(−0.7, 1.4)

0.525

Hemoglobin (Hb)

0.4

(−7.5, 8.3)

0.925

18.7

(6.7, 30.7)

0.002